<?xml version="1.0" encoding="UTF-8"?>
<p>As clinical and epidemiologic information on SARS-CoV-2 infection have increased, a better knowledge on the burden of severe disease and clinical risk factors associated with disease progression have emerged. Older age, male gender, and pre-existing chronic conditions, such as diabetes, obesity, cardiovascular disease, have been observed to be the most significant risk factors among patients with COVID-19 in China and Europe [
 <xref rid="B7-vaccines-08-00224" ref-type="bibr">7</xref>,
 <xref rid="B8-vaccines-08-00224" ref-type="bibr">8</xref>,
 <xref rid="B9-vaccines-08-00224" ref-type="bibr">9</xref>]. In the United States disproportionately higher rates of hospitalization and death have been reported among African-American and Hispanic groups and may be explained by differences in economic and social conditions of ethnic minorities in specific contexts. Nevertheless, genetic contribution to different clinical outcomes cannot be excluded [
 <xref rid="B10-vaccines-08-00224" ref-type="bibr">10</xref>].
</p>
